The 2nd International Invasive Lobular Breast Cancer Symposium will focus on various topics in primary and metastatic invasive lobular breast cancer (ILC), and lobular carcinoma in situ (LCIS). This year, it is a pleasure to host two keynote talks from Dr. Christine Desmedt (Katholieke Universiteit Leuven, Leuven, Belgium) and Dr. Tari A. King (Dana-Farber-Cancer Institute, Boston, USA). The first day of the Symposium will focus on education of patients with ILC, breast cancer advocates, their families, and other caregivers. This will be followed by a day and a half of talks from outstanding Faculty and trainees about the latest discoveries in the laboratories and the progress being made in the clinic. For detailed information visit the symposium website, http://ilcsymposium2020.com/.
2nd International Invasive Lobular Breast Cancer Symposium (ILC)
Breast cancer remains the major cause of cancer related deaths among women. For 2019, American Cancer Society estimates ~268,600 new cases and 41,760 associated deaths in the United States. Worldwide, approximately 2.1 million new female breast cancer cases will be diagnosed in 2019. Invasive lobular cancer (ILC) is the second most common histological subtype of breast cancers, after the more common subtype of invasive ductal cancer (IDC). ILC accounts for ~10%-15% of all breast cancers (~39,000 annually in the US) and ranks as the 6th most commonly diagnosed cancer in women in the US. ILC has been chronically understand, however, there is an increasing appreciation of unique clinical and biological aspects of the disease that require additional research. There is a need for more interactions and collaborations between researchers, clinicians and patient advocates in order to better understand ILC with the final goal to improve outcome for thousands of women affected globally by this sneaky disease.
The 2nd International ILC Symposium will bring together national and international experts presenting new findings from basic, translational and clinical research. The symposium will also focus on the education of patients with ILC, breast cancer advocates, their families, and other caregivers. The advocacy bootcamp on May 14th will be led by the Lobular Breast Cancer Alliance (LBCA) advocates for ILC research. We expect that the presentations and discussions will lead to improved understanding of ILC and new ideas for personalizing therapy for patients with ILC. In addition, this symposium will continue to forge new collaborations between the community of basic researchers, clinicians and breast cancer advocates that will ultimately lead to improved outcome for patients suffering with ILC.
At the conclusion of the symposium, attendees should have:
1) A greater appreciation for common and unique characteristics of primary and metastatic ILC.
2) A more complete understanding of treatment responses in patients with ILC.
3) An expanded knowledge of options for patients with ILC such as patient selection for neoadjuvant versus adjuvant therapies, breast conserving surgery, and more.
4) An ability to understand and discuss the role of biomarkers and genomic analysis in characterization of ILC
For additional information including a special group rate for your overnight stay visit, http://ilcsymposium2020.com/symposium-venue.
Attendees who are flying should make plans to travel to the Pittsburgh International Airport. The airport is approximately 20 miles from the conference venue/hotel and downtown Pittsburgh.
Parking is available at the Conference Hotel/Venue. Current overnight parking rates are $30.00 for valet and $26.00 for garage per day, both of these options are with In/Out privileges. Parking is owned and operated by hotel.
For additional travel information visit, http://ilcsymposium2020.com/symposium-venue.
This activity is approved for the following credit: AMA PRA Category 1 Credit™. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 0.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.25 Attendance
Special Event: Gateway Clipper Boat Tour; includes dinner, drink tickets and transportation to/from the dock $20
The boat will depart on Friday, May 15, 2020 with a docking time of 6pm and cruising time from 6:30-9pm. The cost for this boat tour is $20 and transportation to and from the dock will be provided. If interested, please be sure to include this option while registering. Additional information will be provided to those who register for this event. Please direct any questions to Nadine Ryan; email@example.com.
Food Service: Food service will include breakfast, lunch, and coffee breaks each day of the symposium. Dinner will be provided on Friday evening while viewing the beautiful sights of Pittsburgh on board the Gateway Clipper Fleet. Please refer to the registration page under “Extra” for more information. Please be sure to include this option while registering. If you have any special dietary needs, please contact the Symposium Coordinator.
Special Needs: Participation by all individuals is encouraged. Advanced notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the symposium by contacting the Symposium Coordinator.
Cancellation Policy: All cancellations and refund requests must be submitted at http://cce.upmc.com/refund. Tuition for cancellations received before April 24, 2020 will be refunded in full. April 24, 2020, a $25 administrative fee will be assessed, the remaining amount refunded, and no refunds will be made after May 1, 2020.